Key result
Higher modified cardiometabolic index linked to ~32% increased incident stroke risk per unit increase.
Why the study?
The association between the modified cardiometabolic index and stroke risk remains unclear.
Does a higher modified cardiometabolic index (MCMI) increase the risk of incident stroke in Chinese adults aged 45 and older?
Cohort (n=8,167)
Yes
Does a higher modified cardiometabolic index (MCMI) increase the risk of incident stroke in Chinese adults aged 45 and older?
Higher modified cardiometabolic index (MCMI) is independently associated with an increased risk of incident stroke and offers modestly better predictive performance than the standard cardiometabolic index.
Answers are grounded in this paper and cite their sources.
MCMI may aid stroke risk stratification in Chinese adults ≥45 years; extends cardiometabolic index evidence but remains hypothesis-generating.
The association between the modified cardiometabolic index (MCMI) and stroke risk remains unclear. This study aimed to investigate the relationship between MCMI and incident stroke. A total of 8167 participants from the China Health and Retirement Longitudinal Study (baseline 2011) were included. MCMI was calculated as ln[triglycerides × fasting blood glucose/ high-density lipoprotein cholesterol] × waist circumference/ height. Incident stroke was defined as self-reported physician-diagnosed stroke during follow-up through 2020. Cox proportional hazards regression, restricted cubic spline (RCS) modeling, and subgroup analyses were performed to examine the association. Time-dependent receiver operating characteristic (ROC) analysis was used to compare the predictive performance of MCMI with that of the cardiometabolic index (CMI). Over 9 years of follow-up, higher MCMI levels were associated with increased stroke risk (hazard ratio [HR] = 1.32, 95% confidence interval [CI]: 1.20–1.46). Quartile analyses confirmed this trend, with the highest quartile showing the greatest risk compared with the lowest (HR = 2.30, 95% CI: 1.80–2.94). RCS analysis revealed a nonlinear relationship (P for nonlinearity = 0.002). Subgroup analyses suggested potential heterogeneity across marital status and residential location. ROC analysis showed that the MCMI consistently yielded higher AUC values than the CMI at 3 years (0.72 vs 0.70), 5 years (0.75 vs 0.73), 7 years (0.77 vs 0.75), and 8 years (0.72 vs 0.70), with all DeLong’s test P-values < 0.05. Higher MCMI levels were positively associated with stroke risk. Although MCMI demonstrated slightly better predictive performance than CMI, the improvement was limited. These findings support an association rather than direct clinical applicability. Additional large-scale prospective studies and validation analyses are required before its routine use in clinical risk stratification can be considered.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) conducted a cohort in Stroke risk (n=8,167). Modified cardiometabolic index (MCMI) vs. Lower MCMI levels was evaluated on Incident stroke (HR 1.32, 95% CI 1.20-1.46, p=<0.001). Higher modified cardiometabolic index levels were independently associated with an increased risk of incident stroke.
Synapse has enriched 10 related papers. Consider them for comparative context: